VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1596088
Sex: M
Age: 93
State: FL

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: tingling in right hand; injection site pain; A spontaneous report was received from a consumer concerning a 94-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain soreness at the injection site, tingling in his right hand. The patient's medical history was not provided. No relevant concomitant medications were reported. On 12 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 031M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 12 Feb 2021, the patient experienced the event(s) pain soreness at the injection site. tingling in his right hand. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), pain soreness at the injection site, tingling in his right hand was unknown.

Other Meds:

Current Illness:

ID: 1596089
Sex: M
Age: 66
State: AZ

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Pain in back of neck; Pain in shoulders; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain in back of neck) and ARTHRALGIA (Pain in shoulders) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NECK PAIN (Pain in back of neck) and ARTHRALGIA (Pain in shoulders). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, NECK PAIN (Pain in back of neck) and ARTHRALGIA (Pain in shoulders) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1596090
Sex: F
Age: 46
State: TX

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Itchy torso; Right hand numbness; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itchy torso) and HYPOAESTHESIA (Right hand numbness) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension, Colitis, Migraine, Irritable bowel syndrome, Psoriasis and Allergy (The patient is allergic to ACE inhibitors.). Concomitant products included LEVONORGESTREL (MIRENA) for Intrauterine contraception, MONTELUKAST SODIUM (SINGULAIR), TRAZODONE HYDROCHLORIDE, RIMEGEPANT SULFATE, ONDANSETRON (ZOFRAN MELT) and BOTULINUM TOXIN TYPE A (BOTOX) for an unknown indication. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PRURITUS (Itchy torso) and HYPOAESTHESIA (Right hand numbness). At the time of the report, PRURITUS (Itchy torso) and HYPOAESTHESIA (Right hand numbness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided.

Other Meds: SINGULAIR; TRAZODONE HYDROCHLORIDE; RIMEGEPANT SULFATE; ZOFRAN MELT; BOTOX; MIRENA

Current Illness: Allergy (The patient is allergic to ACE inhibitors.); Colitis; Hypertension; Irritable bowel syndrome; Migraine; Psoriasis

ID: 1596091
Sex: M
Age: 67
State: IL

Vax Date: 02/04/2021
Onset Date: 02/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: itchy; it felt like blisters; redness head spread from his deltoid down to his elbow; oozing from the injection site; arm felt tight; warm to the touch; red; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events oozing from the injection site, arm felt tight, warm to the touch, red, itchy, redness head spread from his deltoid down to his elbow, it felt like blisters. The patient's medical history was not provided. Concomitant medications reported were lantus, Janumet, Glimepiride, Protonix, Atorvastatin, Telmisartan for drug use for unknown indication. On 4 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 11 Feb 2021, the patient experienced the event(s) oozing from the injection site. arm felt tight, warm to the touch, red, itchy. On 12 Feb 2021, the patient experienced the event(s) redness head spread from his deltoid down to his elbow. it felt like blisters. Treatment details included Benadryl and Benadryl cream. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), oozing from the injection site, arm felt tight, warm to the touch, red, itchy, redness head spread from his deltoid down to his elbow, it felt like blisters was unknown.

Other Meds: LANTUS; JANUMET; GLIMEPIRIDE; PROTONIX [OMEPRAZOLE]; ATORVASTATIN; TELMISARTAN

Current Illness:

ID: 1596092
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: "burning sensation that lasted on & off about 2 weeks"; "trouble breathing for a day"; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION ("burning sensation that lasted on & off about 2 weeks") and DYSPNOEA ("trouble breathing for a day") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION ("burning sensation that lasted on & off about 2 weeks") and DYSPNOEA ("trouble breathing for a day"). At the time of the report, BURNING SENSATION ("burning sensation that lasted on & off about 2 weeks") and DYSPNOEA ("trouble breathing for a day") outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medications reported was not provided. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1596093
Sex: F
Age:
State: PA

Vax Date: 12/28/2020
Onset Date: 01/28/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: COVID-19 diagnose after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 diagnose after vaccination) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure fluctuation. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN D NOS for an unknown indication, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP). On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced COVID-19 (COVID-19 diagnose after vaccination). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19 diagnose after vaccination) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, SARS-CoV-2 test positive: positive (Positive) Positive. Treatment includes Apure. Reporter did not allow further contact

Other Meds: BABY ASPIRIN; VITAMIN D NOS; VITAMIN C & ROSEHIP

Current Illness: Blood pressure fluctuation

ID: 1596094
Sex: F
Age: 76
State: NM

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: bright red hives all over her body; itching; burning; A spontaneous report was received from a consumer concerning a 86-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events bright red hives all over her body, itching, burning. The patient's medical history was eczema. She has applying a cream it seems to be helpful. On 9 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) unknown route for prophylaxis of COVID-19 infection. On 9 Feb 2021, the patient experienced the event(s) bright red hives all over her body. itching, burning. Treatment details included She has been applying a cream and it seems to be helping.. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), bright red hives all over her body, itching,burning was unknown.

Other Meds:

Current Illness:

ID: 1596095
Sex: F
Age:
State:

Vax Date: 02/12/2021
Onset Date: 02/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Side effects post vaccination; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects post vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced ADVERSE EVENT (Side effects post vaccination). At the time of the report, ADVERSE EVENT (Side effects post vaccination) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. Concomitant medication was not provided.

Other Meds:

Current Illness:

ID: 1596096
Sex: F
Age: 78
State: CA

Vax Date: 01/29/2021
Onset Date: 02/06/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Vaccine related skin reaction/allergic reaction; Spreading and cellulitis-like near vaccination site upper L arm; Bump on injection site; Redness; Itching sometimes/itchiness/scratching injection site; This spontaneous case was reported by a health care professional and describes the occurrence of DERMATITIS ALLERGIC (Vaccine related skin reaction/allergic reaction), VACCINATION SITE CELLULITIS (Spreading and cellulitis-like near vaccination site upper L arm), VACCINATION SITE PRURITUS (Itching sometimes/itchiness/scratching injection site), VACCINATION SITE SWELLING (Bump on injection site) and VACCINATION SITE ERYTHEMA (Redness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included Blepharitis and Cataract. Concurrent medical conditions included Allergy (Allergy to cefaclor, sulfamethoxazole trimethoprim). Concomitant products included DINOPROSTONE, CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and VITAMIN B COMPLEX for an unknown indication, FISH OIL, OENOTHERA BIENNIS OIL, TOCOPHERYL ACETATE (OMEGA 3 & 6). On 29-Jan-2021 at 3:19 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching sometimes/itchiness/scratching injection site). On an unknown date, the patient experienced DERMATITIS ALLERGIC (Vaccine related skin reaction/allergic reaction), VACCINATION SITE CELLULITIS (Spreading and cellulitis-like near vaccination site upper L arm), VACCINATION SITE SWELLING (Bump on injection site) and VACCINATION SITE ERYTHEMA (Redness). The patient was treated with LORATADINE at a dose of 10 mg. At the time of the report, DERMATITIS ALLERGIC (Vaccine related skin reaction/allergic reaction), VACCINATION SITE CELLULITIS (Spreading and cellulitis-like near vaccination site upper L arm), VACCINATION SITE PRURITUS (Itching sometimes/itchiness/scratching injection site), VACCINATION SITE SWELLING (Bump on injection site) and VACCINATION SITE ERYTHEMA (Redness) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment also includes Azithromycin and sulfamethoxazole trimethoprim. lab test also includes CBC w/diff, CMP, CRP drawn on 02/09/2021.

Other Meds: DINOPROSTONE; CALCIUM; VITAMIN D 2000; OMEGA 3 & 6; VITAMIN B COMPLEX

Current Illness: Allergy (Allergy to cefaclor, sulfamethoxazole trimethoprim)

ID: 1596097
Sex: F
Age: 50
State: OH

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: tingle in arm; pain from her collar bone to the tip of her fingers; shoulder blade was painful and if felt like arthritis; sweat on her forehead; felt feverish; blood pressure was 135/90; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingle in arm), PAIN (pain from her collar bone to the tip of her fingers), ARTHRALGIA (shoulder blade was painful and if felt like arthritis), HYPERHIDROSIS (sweat on her forehead) and PYREXIA (felt feverish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR) for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PARAESTHESIA (tingle in arm), PAIN (pain from her collar bone to the tip of her fingers), ARTHRALGIA (shoulder blade was painful and if felt like arthritis), HYPERHIDROSIS (sweat on her forehead), PYREXIA (felt feverish) and BLOOD PRESSURE ABNORMAL (blood pressure was 135/90). At the time of the report, PARAESTHESIA (tingle in arm), PAIN (pain from her collar bone to the tip of her fingers), ARTHRALGIA (shoulder blade was painful and if felt like arthritis), HYPERHIDROSIS (sweat on her forehead), PYREXIA (felt feverish) and BLOOD PRESSURE ABNORMAL (blood pressure was 135/90) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 135/90 135/90 Patient states he blood pressure is usually low.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient used a heating pad to help alleviate the pain.

Other Meds: BENADRYL 24 D; SUDAFED 12 HOUR

Current Illness:

ID: 1596098
Sex: F
Age: 67
State: CA

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: A lot of pain in the arm (left) where the injection was placed; Could not lift arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (A lot of pain in the arm (left) where the injection was placed) and VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE PAIN (A lot of pain in the arm (left) where the injection was placed) and VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (A lot of pain in the arm (left) where the injection was placed) and VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not provided. Treatment includes warm and cold compress alternately, aspirin cream on the area. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1596099
Sex: F
Age: 67
State: FL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (minor arm pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 030L20A) for COVID-19 immunization. No medical history information reported. On Jan 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 22, 2021, patient experienced pain in extremity (minor arm pain). At the time of the report, pain in extremity (minor arm pain) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information reported.

Other Meds:

Current Illness:

ID: 1596100
Sex: F
Age: 75
State: NC

Vax Date: 01/28/2021
Onset Date: 02/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Itching; Rash; Rash is hard to the touch; 3 red spots; Rash warm to the touch; Pain; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (3 red spots), VACCINATION SITE WARMTH (Rash warm to the touch), PAIN (Pain), PRURITUS (Itching) and RASH (Rash) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported by the reporter. Concomitant products included ATENOLOL, ATORVASTATIN, AMLODIPINE, ACETYLSALICYLIC ACID (BABY ASPIRIN), LOSARTAN POTASSIUM (LOSARTIN) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced RASH MACULAR (3 red spots), VACCINATION SITE WARMTH (Rash warm to the touch), PAIN (Pain), RASH (Rash) and INJECTION SITE INDURATION (Rash is hard to the touch). On 05-Feb-2021, the patient experienced PRURITUS (Itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RASH MACULAR (3 red spots), VACCINATION SITE WARMTH (Rash warm to the touch), PAIN (Pain), PRURITUS (Itching), RASH (Rash) and INJECTION SITE INDURATION (Rash is hard to the touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds: ATENOLOL; ATORVASTATIN; AMLODIPINE; BABY ASPIRIN; LOSARTIN; VITAMIN D 3

Current Illness:

ID: 1596101
Sex: M
Age: 31
State: AK

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: feeling not well; headaches; pain at the injection site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MALAISE (feeling not well), HEADACHE (headaches) and INJECTION SITE PAIN (pain at the injection site) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 10-Feb-2021, the patient experienced MALAISE (feeling not well), HEADACHE (headaches) and INJECTION SITE PAIN (pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), MALAISE (feeling not well) and HEADACHE (headaches) was resolving and INJECTION SITE PAIN (pain at the injection site) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1596102
Sex: F
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: allergic reactions; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reactions) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced HYPERSENSITIVITY (allergic reactions). At the time of the report, HYPERSENSITIVITY (allergic reactions) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596103
Sex: F
Age: 77
State: FL

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: fever 101.9F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 101.9F) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes and Blood pressure high. On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PYREXIA (fever 101.9F). At the time of the report, PYREXIA (fever 101.9F) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Body temperature: (High) 101.9F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Blood pressure high; Diabetes

ID: 1596104
Sex: M
Age: 75
State:

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: tested positive for COVID-19 after vaccination; flu like/cold like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like/cold like symptoms) and COVID-19 (tested positive for COVID-19 after vaccination) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like/cold like symptoms). On 12-Feb-2021, the patient experienced COVID-19 (tested positive for COVID-19 after vaccination). On 12-Feb-2021, INFLUENZA LIKE ILLNESS (flu like/cold like symptoms) had resolved. At the time of the report, COVID-19 (tested positive for COVID-19 after vaccination) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, SARS-CoV-2 test: (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications reported were Medication for hypertension. No treatment information was provided.

Other Meds:

Current Illness: Hypertension

ID: 1596105
Sex: M
Age:
State: GA

Vax Date:
Onset Date: 02/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Diagnosed with positive COVID-19 a couple of days after receiving the Moderna COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with positive COVID-19 a couple of days after receiving the Moderna COVID-19) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced COVID-19 (Diagnosed with positive COVID-19 a couple of days after receiving the Moderna COVID-19). At the time of the report, COVID-19 (Diagnosed with positive COVID-19 a couple of days after receiving the Moderna COVID-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596106
Sex: F
Age: 60
State: SC

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Impetigo; Sore arm; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of IMPETIGO (Impetigo) and VACCINATION SITE PAIN (Sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 12-Feb-2021, the patient experienced IMPETIGO (Impetigo). On 11-Feb-2021, VACCINATION SITE PAIN (Sore arm) had resolved. At the time of the report, IMPETIGO (Impetigo) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596107
Sex: F
Age: 75
State: WI

Vax Date: 02/03/2021
Onset Date: 02/12/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Warm at the injection arm; itches at the injection arm; Redness at the injection arm; Swelling at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm at the injection arm), VACCINATION SITE PRURITUS (itches at the injection arm), VACCINATION SITE ERYTHEMA (Redness at the injection arm) and VACCINATION SITE SWELLING (Swelling at the injection arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm at the injection arm), VACCINATION SITE PRURITUS (itches at the injection arm), VACCINATION SITE ERYTHEMA (Redness at the injection arm) and VACCINATION SITE SWELLING (Swelling at the injection arm). At the time of the report, VACCINATION SITE WARMTH (Warm at the injection arm), VACCINATION SITE PRURITUS (itches at the injection arm), VACCINATION SITE ERYTHEMA (Redness at the injection arm) and VACCINATION SITE SWELLING (Swelling at the injection arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication information was provided. No treatment medication information was provided.

Other Meds:

Current Illness:

ID: 1596108
Sex: F
Age:
State: FL

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: diagnosed with Covid19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosed with Covid19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (diagnosed with Covid19). At the time of the report, COVID-19 (diagnosed with Covid19) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596109
Sex: F
Age: 54
State: MO

Vax Date: 01/15/2021
Onset Date: 02/12/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Shingles; bright red rash on the abdomen; severe stomach cramps; body aches; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), RASH ERYTHEMATOUS (bright red rash on the abdomen), ABDOMINAL PAIN UPPER (severe stomach cramps), MYALGIA (body aches) and HEADACHE (headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced RASH ERYTHEMATOUS (bright red rash on the abdomen), ABDOMINAL PAIN UPPER (severe stomach cramps), MYALGIA (body aches), HEADACHE (headache) and CHILLS (chills). On 10-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of UNK dosage form. On 12-Feb-2021, RASH ERYTHEMATOUS (bright red rash on the abdomen) had resolved. At the time of the report, HERPES ZOSTER (Shingles) had resolved and ABDOMINAL PAIN UPPER (severe stomach cramps), MYALGIA (body aches), HEADACHE (headache) and CHILLS (chills) had not resolved. No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to events was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow-up received on 19-jun-2021, event shingles was added.

Other Meds:

Current Illness:

ID: 1596110
Sex: M
Age: 77
State: TX

Vax Date: 02/02/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). At the time of the report, PAIN IN EXTREMITY (Arm soreness) had not resolved. Not Provided No concomitant medications were reported. No treatment information was reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1596111
Sex: F
Age: 73
State: FL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: migraine; first dose of Moderna COVID-19 vaccine around FEB2021 & Never got the Second shot; Swollen (Right Lip); This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen (Right Lip)), MIGRAINE (migraine) and PRODUCT DOSE OMISSION ISSUE (first dose of Moderna COVID-19 vaccine around FEB2021 & Never got the Second shot) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced LIP SWELLING (Swollen (Right Lip)). On 04-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose of Moderna COVID-19 vaccine around FEB2021 & Never got the Second shot). On an unknown date, the patient experienced MIGRAINE (migraine). At the time of the report, LIP SWELLING (Swollen (Right Lip)) had not resolved, MIGRAINE (migraine) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (first dose of Moderna COVID-19 vaccine around FEB2021 & Never got the Second shot) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication provided. No treatment medication provided. patients reaction on the side of her lip is still going on. She has been to doctors and MRI/CT-Scan shows everything is normal. She states that she would like to receive the second dose of the COVID-19 vaccine but nobody is willing to give it to her because of her reaction. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21-JUL-2021 contained: Updated contact details- Email ID; On 04-Aug-2021: Follow-up received: Event added

Other Meds:

Current Illness:

ID: 1596112
Sex: F
Age: 76
State: NC

Vax Date: 02/11/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Left arm (the whole arm) is swollen; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Left arm (the whole arm) is swollen) and HEADACHE (Severe headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Left arm (the whole arm) is swollen) and HEADACHE (Severe headache). At the time of the report, PERIPHERAL SWELLING (Left arm (the whole arm) is swollen) and HEADACHE (Severe headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596113
Sex: F
Age: 49
State: PA

Vax Date: 01/13/2021
Onset Date: 02/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Excruciating headache; Chills; Fatigue; Slight nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Excruciating headache), CHILLS (Chills), FATIGUE (Fatigue) and NAUSEA (Slight nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN), MAGNESIUM, DIPHENHYDRAMINE, PARACETAMOL, PHENYLPROPANOLAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE;PARACETAMOL;PHENYLPROPANOLAMINE HYDROCHLORIDE]), MULTIVITAMINS [VITAMINS NOS], VITAMIN D [VITAMIN D NOS], FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and FERRIC CARBOXYMALTOSE (INJECTAFER) for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021 at 2:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced HEADACHE (Excruciating headache), CHILLS (Chills), FATIGUE (Fatigue) and NAUSEA (Slight nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 11-Feb-2021, CHILLS (Chills), FATIGUE (Fatigue) and NAUSEA (Slight nausea) had resolved. At the time of the report, HEADACHE (Excruciating headache) had not resolved. Not Provided

Other Meds: LEXAPRO; WELLBUTRIN; MAGNESIUM; BENADRYL [DIPHENHYDRAMINE;PARACETAMOL;PHENYLPROPANOLAMINE HYDROCHLORIDE]; MULTIVITAMINS [VITAMINS NOS]; VITAMIN D [VITAMIN D NOS]; FLONASE ALLERGY RELIEF; INJECTAFER

Current Illness:

ID: 1596114
Sex: F
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Red rash in her injection arm; Red rash in her injection arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Red rash in her injection arm) and VACCINATION SITE ERYTHEMA (Red rash in her injection arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Red rash in her injection arm) and VACCINATION SITE ERYTHEMA (Red rash in her injection arm). At the time of the report, VACCINATION SITE PRURITUS (Red rash in her injection arm) and VACCINATION SITE ERYTHEMA (Red rash in her injection arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant Concomitant medications were reported. No Treatment for the event was provided.

Other Meds:

Current Illness:

ID: 1596115
Sex: F
Age: 80
State:

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: itching; hot to touch; injection site red circles; local redness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (local redness), PRURITUS (itching), FEELING HOT (hot to touch) and INJECTION SITE ERYTHEMA (injection site red circles) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. Concurrent medical conditions included Sensitive skin, Skin disorder NOS and Allergy to antibiotic. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced ERYTHEMA (local redness). On 06-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (injection site red circles). On 12-Feb-2021, the patient experienced PRURITUS (itching) and FEELING HOT (hot to touch). On 10-Feb-2021, INJECTION SITE ERYTHEMA (injection site red circles) had resolved. At the time of the report, ERYTHEMA (local redness) outcome was unknown and PRURITUS (itching) and FEELING HOT (hot to touch) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.; Reporter's Comments: The event little more red. itching again, as reoccurred its not coded, its mentioned in the narrative

Other Meds:

Current Illness: Allergy to antibiotic; Sensitive skin; Skin disorder NOS

ID: 1596116
Sex: U
Age:
State:

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: got Covid between the first and second shot,; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got Covid between the first and second shot,) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included SARS-CoV-2 infection. On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got Covid between the first and second shot,). At the time of the report, COVID-19 (got Covid between the first and second shot,) outcome was unknown. No concomitant medications were given No treatment information was provided Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Additional information received

Other Meds:

Current Illness:

ID: 1596117
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Side effects Post first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects Post first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects Post first dose). At the time of the report, VACCINATION COMPLICATION (Side effects Post first dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.; Reporter's Comments: unspecified adverse event as reported

Other Meds:

Current Illness:

ID: 1596118
Sex: F
Age: 42
State: NJ

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Congestion; Warm Eyes; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY TRACT CONGESTION (Congestion), ABNORMAL SENSATION IN EYE (Warm Eyes), CHILLS (Chills) and HEADACHE (Headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RESPIRATORY TRACT CONGESTION (Congestion), ABNORMAL SENSATION IN EYE (Warm Eyes), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RESPIRATORY TRACT CONGESTION (Congestion), ABNORMAL SENSATION IN EYE (Warm Eyes), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1596119
Sex: F
Age:
State: IL

Vax Date: 01/18/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Change in taste sense; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Change in taste sense) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Change in taste sense). At the time of the report, DYSGEUSIA (Change in taste sense) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. On an unknown date, the patient experienced change in taste sense. The patient has done multiple COVID tests with results returned negative. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1596120
Sex: F
Age:
State: FL

Vax Date: 02/01/2021
Onset Date: 02/10/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Red rash on vaccination site; Rash has spread into a circle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SCAR (Rash has spread into a circle) and VACCINATION SITE RASH (Red rash on vaccination site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE SCAR (Rash has spread into a circle). On an unknown date, the patient experienced VACCINATION SITE RASH (Red rash on vaccination site). At the time of the report, VACCINATION SITE SCAR (Rash has spread into a circle) and VACCINATION SITE RASH (Red rash on vaccination site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596121
Sex: F
Age: 65
State: OH

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Left ear feels numb; Side of face feels numb; Numbness in lips, lips still feel numb; lips felt swollen; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lips felt swollen), HYPOAESTHESIA ORAL (Numbness in lips, lips still feel numb), HYPOAESTHESIA (Side of face feels numb) and HYPOAESTHESIA (Left ear feels numb) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included PITAVASTATIN CALCIUM (LIVALO) and VITAMINS NOS for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced LIP SWELLING (lips felt swollen) and HYPOAESTHESIA ORAL (Numbness in lips, lips still feel numb). On 12-Feb-2021, the patient experienced HYPOAESTHESIA (Side of face feels numb) and HYPOAESTHESIA (Left ear feels numb). The patient was treated with LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN EXTRA) for Adverse event, at a dose of UNK dosage form. At the time of the report, LIP SWELLING (lips felt swollen), HYPOAESTHESIA (Side of face feels numb) and HYPOAESTHESIA (Left ear feels numb) outcome was unknown and HYPOAESTHESIA ORAL (Numbness in lips, lips still feel numb) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: LIVALO; VITAMINS NOS

Current Illness:

ID: 1596122
Sex: F
Age: 81
State: TX

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Fever 100.2 Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100.2 Fahrenheit) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PYREXIA (Fever 100.2 Fahrenheit). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever 100.2 Fahrenheit) outcome was unknown. No relevant concomitant medications were reported. This case was linked to MOD-2021-044128 (Patient Link).

Other Meds:

Current Illness:

ID: 1596123
Sex: F
Age: 69
State: FL

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: blood pressure is fine, actually is low; fast heartbeat; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), HEART RATE INCREASED (fast heartbeat) and HYPOTENSION (blood pressure is fine, actually is low) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension and Allergy. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 11-Feb-2021, the patient experienced HEART RATE INCREASED (fast heartbeat). On an unknown date, the patient experienced HYPOTENSION (blood pressure is fine, actually is low). On 12-Feb-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, HEART RATE INCREASED (fast heartbeat) and HYPOTENSION (blood pressure is fine, actually is low) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications details included medications for hypertension and allergies. Treatment details was not reported by the reporter.

Other Meds:

Current Illness: Allergy; Hypertension

ID: 1596124
Sex: M
Age: 78
State: CT

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Patient was diagnosed with Covid-19 two and a half weeks ago with just mild symptoms.). On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) had not resolved and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596125
Sex: F
Age: 44
State: TX

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Hot Arm at injection site; Puffy Arm (Injection Site); Red at injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot Arm at injection site), VACCINATION SITE SWELLING (Puffy Arm (Injection Site)) and VACCINATION SITE ERYTHEMA (Red at injection Site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot Arm at injection site), VACCINATION SITE SWELLING (Puffy Arm (Injection Site)) and VACCINATION SITE ERYTHEMA (Red at injection Site). At the time of the report, VACCINATION SITE WARMTH (Hot Arm at injection site), VACCINATION SITE SWELLING (Puffy Arm (Injection Site)) and VACCINATION SITE ERYTHEMA (Red at injection Site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596126
Sex: F
Age: 66
State: MI

Vax Date: 02/02/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fever; It's gotten bigger, pinkish, kind of a rash but not really a rash; Soreness all over, generally rotten; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (It's gotten bigger, pinkish, kind of a rash but not really a rash), PAIN (Soreness all over, generally rotten), CHILLS (Chills) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (It's gotten bigger, pinkish, kind of a rash but not really a rash), PAIN (Soreness all over, generally rotten), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, VACCINATION SITE REACTION (It's gotten bigger, pinkish, kind of a rash but not really a rash), PAIN (Soreness all over, generally rotten), CHILLS (Chills) and PYREXIA (Fever) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Outcome of event (s) changed from unknown to recovered.

Other Meds:

Current Illness:

ID: 1596127
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Rash on arm 10-11 days since getting the vaccine, getting bigger 4 inches long and 2 inches wide; Little sore - on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on arm 10-11 days since getting the vaccine, getting bigger 4 inches long and 2 inches wide) and VACCINATION SITE PAIN (Little sore - on arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash on arm 10-11 days since getting the vaccine, getting bigger 4 inches long and 2 inches wide) and VACCINATION SITE PAIN (Little sore - on arm). At the time of the report, VACCINATION SITE RASH (Rash on arm 10-11 days since getting the vaccine, getting bigger 4 inches long and 2 inches wide) and VACCINATION SITE PAIN (Little sore - on arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Outcome of the events updated.

Other Meds:

Current Illness:

ID: 1596128
Sex: F
Age: 66
State: MI

Vax Date: 02/02/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Injection site gotten bigger, pinkish, kind of a rash but not really a rash; diarrhea; low grade fever; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (low grade fever) and VACCINATION SITE RASH (Injection site gotten bigger, pinkish, kind of a rash but not really a rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 030A21A) for COVID-19 vaccination. The patient's past medical history included No adverse reaction (No reported medical history). On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced DIARRHOEA (diarrhea) and PYREXIA (low grade fever). On an unknown date, the patient experienced VACCINATION SITE RASH (Injection site gotten bigger, pinkish, kind of a rash but not really a rash). At the time of the report, DIARRHOEA (diarrhea), PYREXIA (low grade fever) and VACCINATION SITE RASH (Injection site gotten bigger, pinkish, kind of a rash but not really a rash) outcome was unknown. No concomitant information was reported. Treatment information was not reported. This case was linked to MOD-2021-034765 (Patient Link).

Other Meds:

Current Illness:

ID: 1596129
Sex: F
Age: 82
State: AZ

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: her arm started to itch; arm started to itch was bright red; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (her arm started to itch), PYREXIA (low grade fever) and ERYTHEMA (arm started to itch was bright red) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043120A) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PRURITUS (her arm started to itch), PYREXIA (low grade fever) and ERYTHEMA (arm started to itch was bright red). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, PRURITUS (her arm started to itch), PYREXIA (low grade fever) and ERYTHEMA (arm started to itch was bright red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported by the reporter.

Other Meds:

Current Illness:

ID: 1596130
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Celiac disease (Medical history reported as medical condition as celiac disease). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness: Celiac disease (Medical history reported as medical condition as celiac disease)

ID: 1596131
Sex: F
Age:
State: MI

Vax Date: 01/31/2021
Onset Date: 02/12/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Her arm is all red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Her arm is all red at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M2A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), OXYCODONE and ACETAMINOPHEN for an unknown indication. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Her arm is all red at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Her arm is all red at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details was not reported by the reporter.

Other Meds: PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]; OXYCODONE; ACETAMINOPHEN

Current Illness:

ID: 1596132
Sex: F
Age:
State:

Vax Date: 03/04/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: not feeling well; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (not feeling well) and HEADACHE (headache). At the time of the report, MALAISE (not feeling well) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was reported. Upon internal review on 21-May-2021, the age was corrected to unknown. This case was linked to MOD21-085138, MOD21-085156, MOD21-14927, MOD21-041180, MOD21-041987 (E2B Linked Report). Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Patient denied to give contact information and consent to follow up was not given.; Sender's Comments: MOD21-085138:follow up - contact information updated MOD21-085156:cross linked id MOD21-14927:cross linked id MOD21-041180:cross linked id MOD21-041987:cross linked id

Other Meds:

Current Illness:

ID: 1596133
Sex: F
Age: 35
State: TX

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 34-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 24-May-2021. On 27-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 27-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was reported.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1596134
Sex: F
Age:
State: FL

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Pain all over her body; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain all over her body) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN (Pain all over her body) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Pain all over her body) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1596135
Sex: F
Age: 64
State: CA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: She didn't have appetite; She felt disgusted; Vomiting; Chills; Little bit Dizzy; My hands and feet were freezing; My body was hot; Body was shaking; My body was cold; I had "heats"; Did not sleep well during the night; I did not feel well; My arm hurt; My feet were freezing; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Body was shaking), INSOMNIA (Did not sleep well during the night), MALAISE (I did not feel well), FEELING COLD (My body was cold) and FEELING HOT (I had "heats") in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included LOVASTATIN, LOSARTAN, AMLODIPINE, HYDROCHLOROTHIAZIDE, ASPIRIN [ACETYLSALICYLIC ACID] and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced INSOMNIA (Did not sleep well during the night), MALAISE (I did not feel well), FEELING HOT (I had "heats"), PAIN IN EXTREMITY (My arm hurt) and PERIPHERAL COLDNESS (My feet were freezing). On 03-Mar-2021, the patient experienced TREMOR (Body was shaking), FEELING COLD (My body was cold), FEELING COLD (My hands and feet were freezing), FEELING HOT (My body was hot ), DIZZINESS (Little bit Dizzy) and CHILLS (Chills). On an unknown date, the patient experienced DECREASED APPETITE (She didn't have appetite), FEELING ABNORMAL (She felt disgusted) and VOMITING (Vomiting). At the time of the report, TREMOR (Body was shaking), INSOMNIA (Did not sleep well during the night), MALAISE (I did not feel well), FEELING COLD (My body was cold), FEELING HOT (I had "heats"), DECREASED APPETITE (She didn't have appetite), PAIN IN EXTREMITY (My arm hurt), PERIPHERAL COLDNESS (My feet were freezing), FEELING COLD (My hands and feet were freezing), FEELING HOT (My body was hot ), FEELING ABNORMAL (She felt disgusted), DIZZINESS (Little bit Dizzy), VOMITING (Vomiting) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 02-Mar-2021, after the first shot administered, the blood pressure reading was taken with altered results. The nurse also suggested the patient to not to take Tylenol or Ibuprofen for 1 week.

Other Meds: LOVASTATIN; LOSARTAN; AMLODIPINE; HYDROCHLOROTHIAZIDE; ASPIRIN [ACETYLSALICYLIC ACID]; ZYRTEC ALLERGY

Current Illness:

ID: 1596136
Sex: F
Age: 80
State: NE

Vax Date: 02/11/2021
Onset Date: 02/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Hasn't been feeling well; Fever; Had aches in her back of her neck; Arm was a little sore; Aches in her shoulder; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Had aches in her back of her neck), PAIN IN EXTREMITY (Arm was a little sore), MALAISE (Hasn't been feeling well), ARTHRALGIA (Aches in her shoulder) and PYREXIA (Fever) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No recorded medical history). On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced NECK PAIN (Had aches in her back of her neck), PAIN IN EXTREMITY (Arm was a little sore), MALAISE (Hasn't been feeling well), ARTHRALGIA (Aches in her shoulder), PYREXIA (Fever) and FATIGUE (Very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Had aches in her back of her neck), PAIN IN EXTREMITY (Arm was a little sore), MALAISE (Hasn't been feeling well), ARTHRALGIA (Aches in her shoulder), PYREXIA (Fever) and FATIGUE (Very tired) outcome was unknown. No concomitant medications reported by investigator

Other Meds:

Current Illness:

ID: 1596137
Sex: M
Age: 74
State: OH

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Feeling "funny" like his breathing was heavier; Weakness; Fatigue; Muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATION ABNORMAL (Feeling "funny" like his breathing was heavier), ASTHENIA (Weakness), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013l20a) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy, Lactose intolerance and Drug allergy (Simvastatin). Concomitant products included ATORVASTATIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, METFORMIN, LEVOTHYROXINE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced RESPIRATION ABNORMAL (Feeling "funny" like his breathing was heavier), ASTHENIA (Weakness), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). On 08-Feb-2021, RESPIRATION ABNORMAL (Feeling "funny" like his breathing was heavier), ASTHENIA (Weakness), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Heart rate: fast (High) Fast. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment information was not provided. Concomitant medication included Vitamins Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: TCR - Consent for FU declined

Other Meds: ATORVASTATIN; LISINOPRIL; HYDROCHLOROTHIAZIDE; METFORMIN; LEVOTHYROXINE; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness: Drug allergy (Simvastatin); Lactose intolerance; Penicillin allergy

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm